Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2021

Open Access 01-12-2021 | Tuberculosis | Research

Patient characteristics associated with different types of prison TB: an epidemiological analysis of 921 TB cases diagnosed at an Ethiopian prison

Authors: Asmah Amirkhani, Maheen Humayun, Wen Ye, Yoseph Worku, Zhenhua Yang

Published in: BMC Pulmonary Medicine | Issue 1/2021

Login to get access

Abstract

Background

Despite incarcerated population being at an increased risk of tuberculosis (TB) and serving as a potential source of TB transmission for the general population, prison TB remains understudied. Given its adverse impact on progress towards TB elimination, World Health Organization (WHO) has identified prison TB research as a top priority to guide TB treatment/control interventions.

Methods

We retrospectively analyzed 921 notified TB cases that were diagnosed at Kality Federal Prison, Ethiopia during 2009–2017. To assess trends of microbiologically confirmed pulmonary TB (PTB), extra-pulmonary TB (EPTB), and TB-HIV co-infection, an ecological analysis of aggregated cases was used to report trends over time. Additionally, we used multivariable log binomial regression to identify patient characteristics associated with microbiologically confirmed PTB, EPTB, and TB-HIV co-infection.

Results

Microbiologically confirmed PTB proportion increased over time. Young age was identified as an important risk factor for EPTB (adjusted prevalence ratio [aPR] = 1.74, 95% CI 0.97, 3.13) while HIV coinfection was negatively associated with EPTB (aPR = 0.73, 95% CI 0.55, 0.97). While previous TB history was associated with a lower likelihood of EPTB (aPR = 0.42, 95% CI 0.25, 0.70), it was associated with an increased risk of TB-HIV coinfection (aPR = 1.37, 95% CI 1.10, 1.71). Clinically diagnosed PTB patients were more likely to have TB-HIV coinfection compared to microbiologically confirmed PTB patients (aPR = 1.32, 95% CI 1.02, 1.72).

Conclusions

Increasing proportion of microbiologically confirmed PTB may suggest delayed access to treatment, severe disease and increased risk of intramural transmission. Associations with clinical/demographic factors varied for different types of TB and were not always consistent with what has been previously reported for the general population, necessitating the need to refocus prison TB control/treatment strategies based on context specific epidemiological factors.
Appendix
Available only for authorised users
Literature
2.
go back to reference Mayer KH, Hamilton CD. Synergistic pandemics: confronting the global HIV and tuberculosis epidemics. Clin Infect Dis. 2010;50:S67–70.CrossRef Mayer KH, Hamilton CD. Synergistic pandemics: confronting the global HIV and tuberculosis epidemics. Clin Infect Dis. 2010;50:S67–70.CrossRef
3.
go back to reference Cha J, Thwaites GE, Ashton PM. An evaluation of progress towards the 2035 WHO End TB targets in 40 high burden countries. medRxiv. 2020. Cha J, Thwaites GE, Ashton PM. An evaluation of progress towards the 2035 WHO End TB targets in 40 high burden countries. medRxiv. 2020.
4.
go back to reference Houben RMGJ, Menzies NA, Sumner T, Huynh GH, Arinaminpathy N, Goldhaber-Fiebert JD, et al. Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models. Lancet Glob Heal. 2016;4(11):e806–15.CrossRef Houben RMGJ, Menzies NA, Sumner T, Huynh GH, Arinaminpathy N, Goldhaber-Fiebert JD, et al. Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models. Lancet Glob Heal. 2016;4(11):e806–15.CrossRef
5.
go back to reference Melese A, Demelash H. The prevalence of tuberculosis among prisoners in Ethiopia: a systematic review and meta-analysis of published studies. Arch Public Health. 2017;75(1):1–9.CrossRef Melese A, Demelash H. The prevalence of tuberculosis among prisoners in Ethiopia: a systematic review and meta-analysis of published studies. Arch Public Health. 2017;75(1):1–9.CrossRef
6.
go back to reference Dara M, Acosta CD, Melchers NVSV, Al-Darraji HAA, Chorgoliani D, Reyes H, et al. Tuberculosis control in prisons: current situation and research gaps. Int J Infect Dis. 2015;32:111–7.CrossRef Dara M, Acosta CD, Melchers NVSV, Al-Darraji HAA, Chorgoliani D, Reyes H, et al. Tuberculosis control in prisons: current situation and research gaps. Int J Infect Dis. 2015;32:111–7.CrossRef
7.
go back to reference Biadglegne F, Rodloff AC, Sack U. Review of the prevalence and drug resistance of tuberculosis in prisons: a hidden epidemic. Epidemiol Infect. 2015;143:887–900.CrossRef Biadglegne F, Rodloff AC, Sack U. Review of the prevalence and drug resistance of tuberculosis in prisons: a hidden epidemic. Epidemiol Infect. 2015;143:887–900.CrossRef
10.
go back to reference Baussano I, Williams BG, Nunn P, Beggiato M, Fedeli U, Scano F. Tuberculosis incidence in prisons: a systematic review. PLoS Med. 2010;7(12):e100038.CrossRef Baussano I, Williams BG, Nunn P, Beggiato M, Fedeli U, Scano F. Tuberculosis incidence in prisons: a systematic review. PLoS Med. 2010;7(12):e100038.CrossRef
11.
go back to reference Fernandez de la Hoz K, Iñigo J, Fernandez-Martín JI, Arce A, Alonso-Sanz M, Gomez-Pintado P, et al. The influence of HIV infection and imprisonment on dissemination of Mycobacterium tuberculosis in a large Spanish city. Int J Tuberc Lung Dis. 2001;5(8):696–702.PubMed Fernandez de la Hoz K, Iñigo J, Fernandez-Martín JI, Arce A, Alonso-Sanz M, Gomez-Pintado P, et al. The influence of HIV infection and imprisonment on dissemination of Mycobacterium tuberculosis in a large Spanish city. Int J Tuberc Lung Dis. 2001;5(8):696–702.PubMed
13.
go back to reference Sahle ET, Blumenthal J, Jain S, Sun S, Young J, Manyazewal T, et al. Bacteriologically-confirmed pulmonary tuberculosis in an Ethiopian prison: prevalence from screening of entrant and resident prisoners. PLoS ONE. 2019;14(12):e0226160.CrossRef Sahle ET, Blumenthal J, Jain S, Sun S, Young J, Manyazewal T, et al. Bacteriologically-confirmed pulmonary tuberculosis in an Ethiopian prison: prevalence from screening of entrant and resident prisoners. PLoS ONE. 2019;14(12):e0226160.CrossRef
15.
go back to reference Kirirabwa NS, Kimuli D, Nanziri C, Sama D, Ntudhu S, Okello DA, et al. A 4-year trend in pulmonary bacteriologically confirmed tuberculosis case detection in Kampala–Uganda. BMC Pulm Med. 2019;19(1):91.CrossRef Kirirabwa NS, Kimuli D, Nanziri C, Sama D, Ntudhu S, Okello DA, et al. A 4-year trend in pulmonary bacteriologically confirmed tuberculosis case detection in Kampala–Uganda. BMC Pulm Med. 2019;19(1):91.CrossRef
17.
go back to reference Amrhein V, Greenland S, McShane B. Scientists rise up against statistical significance. Nature. 2019;567:305–7.CrossRef Amrhein V, Greenland S, McShane B. Scientists rise up against statistical significance. Nature. 2019;567:305–7.CrossRef
19.
go back to reference Edge CL, King EJ, Dolan K, McKee M. Prisoners co-infected with tuberculosis and HIV: a systematic review. J Int AIDS Soc. 2016;19:20960.CrossRef Edge CL, King EJ, Dolan K, McKee M. Prisoners co-infected with tuberculosis and HIV: a systematic review. J Int AIDS Soc. 2016;19:20960.CrossRef
20.
go back to reference Drobniewski FA, Balabanova YM, Ruddy MC, Graham C, Kuznetzov SI, Gusarova GI, et al. Tuberculosis, HIV seroprevalence and intravenous drug abuse in prisoners. Eur Respir J. 2005;26(2):298.CrossRef Drobniewski FA, Balabanova YM, Ruddy MC, Graham C, Kuznetzov SI, Gusarova GI, et al. Tuberculosis, HIV seroprevalence and intravenous drug abuse in prisoners. Eur Respir J. 2005;26(2):298.CrossRef
21.
go back to reference Al-Darraji HAA, Razak HA, Ng KP, Altice FL, Kamarulzaman A. The Diagnostic performance of a single GeneXpert MTB/RIF assay in an intensified tuberculosis case finding survey among HIV-infected prisoners in Malaysia. PLoS ONE. 2013;8(9):e73717.CrossRef Al-Darraji HAA, Razak HA, Ng KP, Altice FL, Kamarulzaman A. The Diagnostic performance of a single GeneXpert MTB/RIF assay in an intensified tuberculosis case finding survey among HIV-infected prisoners in Malaysia. PLoS ONE. 2013;8(9):e73717.CrossRef
22.
go back to reference Shah S, Demissie M, Lambert L, Ahmed J, Leulseged S, Kebede T, et al. Intensified tuberculosis case finding among HIV-infected persons from a voluntary counseling and testing center in Addis Ababa, Ethiopia. J Acquir Immune Defic Syndr. 2009;50(5):537–45.CrossRef Shah S, Demissie M, Lambert L, Ahmed J, Leulseged S, Kebede T, et al. Intensified tuberculosis case finding among HIV-infected persons from a voluntary counseling and testing center in Addis Ababa, Ethiopia. J Acquir Immune Defic Syndr. 2009;50(5):537–45.CrossRef
23.
go back to reference Martino RJ, Chirenda J, Mujuru HA, Ye W, Yang Z. Characteristics indicative of tuberculosis/HIV coinfection in a high-burden setting: lessons from 13,802 incident tuberculosis cases in Harare, Zimbabwe. Am J Trop Med Hyg. 2020;103(1):214–20.CrossRef Martino RJ, Chirenda J, Mujuru HA, Ye W, Yang Z. Characteristics indicative of tuberculosis/HIV coinfection in a high-burden setting: lessons from 13,802 incident tuberculosis cases in Harare, Zimbabwe. Am J Trop Med Hyg. 2020;103(1):214–20.CrossRef
24.
go back to reference Qian X, Nguyen DT, Lyu J, Albers AE, Bi X, Graviss EA. Risk factors for extrapulmonary dissemination of tuberculosis and associated mortality during treatment for extrapulmonary tuberculosis article. Emerg Microbes Infect. 2018;7(1):1–14.CrossRef Qian X, Nguyen DT, Lyu J, Albers AE, Bi X, Graviss EA. Risk factors for extrapulmonary dissemination of tuberculosis and associated mortality during treatment for extrapulmonary tuberculosis article. Emerg Microbes Infect. 2018;7(1):1–14.CrossRef
25.
go back to reference Wang X, Yang Z, Fu Y, Zhang G, Wang X, Zhang Y, et al. Insight to the epidemiology and risk factors of extrapulmonary tuberculosis in Tianjin, China during 2006–2011. PLoS ONE. 2014;9(12):e112213.CrossRef Wang X, Yang Z, Fu Y, Zhang G, Wang X, Zhang Y, et al. Insight to the epidemiology and risk factors of extrapulmonary tuberculosis in Tianjin, China during 2006–2011. PLoS ONE. 2014;9(12):e112213.CrossRef
26.
go back to reference Okonko IO, Anyanwu A, Osadebe AU, Odu NN. HIV and tuberculosis co-infection in a highly HIV-infected population of rivers state, Nigeria. J Immunoass Immunochem. 2018;39(6):636–46.CrossRef Okonko IO, Anyanwu A, Osadebe AU, Odu NN. HIV and tuberculosis co-infection in a highly HIV-infected population of rivers state, Nigeria. J Immunoass Immunochem. 2018;39(6):636–46.CrossRef
27.
go back to reference Méda ZC, Sombié I, Sanon OWC, Maré D, Morisky DE, Chen YMA. Risk factors of tuberculosis infection among HIV/AIDS patients in Burkina Faso. AIDS Res Hum Retroviruses. 2013;29(7):1045–55.CrossRef Méda ZC, Sombié I, Sanon OWC, Maré D, Morisky DE, Chen YMA. Risk factors of tuberculosis infection among HIV/AIDS patients in Burkina Faso. AIDS Res Hum Retroviruses. 2013;29(7):1045–55.CrossRef
28.
go back to reference Tola A, Mishore KM, Ayele Y, Mekuria AN, Legese N. Treatment outcome of tuberculosis and associated factors among TB-HIV co-infected patients at public hospitals of Harar Town, Eastern Ethiopia. A 5-year retrospective study. BMC Public Health. 2019;19(1):1–12.CrossRef Tola A, Mishore KM, Ayele Y, Mekuria AN, Legese N. Treatment outcome of tuberculosis and associated factors among TB-HIV co-infected patients at public hospitals of Harar Town, Eastern Ethiopia. A 5-year retrospective study. BMC Public Health. 2019;19(1):1–12.CrossRef
29.
go back to reference Yang Z, Kong Y, Wilson F, Foxman B, Fowler AH, Marrs CF, et al. Identification of risk factors for extrapulmonary tuberculosis. Clin Infect Dis. 2004;38(2):199–205.CrossRef Yang Z, Kong Y, Wilson F, Foxman B, Fowler AH, Marrs CF, et al. Identification of risk factors for extrapulmonary tuberculosis. Clin Infect Dis. 2004;38(2):199–205.CrossRef
30.
go back to reference Thompson ML, Myers JE, Kriebel D. Prevalence odds ratio or prevalence ratio in the analysis of cross sectional data: what is to be done? Occup Environ Med. 1998;55(4):272–7.CrossRef Thompson ML, Myers JE, Kriebel D. Prevalence odds ratio or prevalence ratio in the analysis of cross sectional data: what is to be done? Occup Environ Med. 1998;55(4):272–7.CrossRef
31.
go back to reference Fonseca Martinez BA, Leotti VB, de Sousa e Silva G, Nunes LN, Machado G, Corbellini LG. Odds ratio or prevalence ratio? An overview of reported statistical methods and appropriateness of interpretations in cross-sectional studies with dichotomous outcomes in veterinary medicine. Front Vet Sci. 2017;4(NOV):193.CrossRef Fonseca Martinez BA, Leotti VB, de Sousa e Silva G, Nunes LN, Machado G, Corbellini LG. Odds ratio or prevalence ratio? An overview of reported statistical methods and appropriateness of interpretations in cross-sectional studies with dichotomous outcomes in veterinary medicine. Front Vet Sci. 2017;4(NOV):193.CrossRef
Metadata
Title
Patient characteristics associated with different types of prison TB: an epidemiological analysis of 921 TB cases diagnosed at an Ethiopian prison
Authors
Asmah Amirkhani
Maheen Humayun
Wen Ye
Yoseph Worku
Zhenhua Yang
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2021
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-021-01699-w

Other articles of this Issue 1/2021

BMC Pulmonary Medicine 1/2021 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.